# Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder

> **NCT03494738** · — · UNKNOWN · sponsor: **CAMC Health System** · enrollment: 600 (actual)

## Conditions studied

- Fetal Alcohol Spectrum Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03494738
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-12
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03494738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03494738, "Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT03494738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*